By John Harbison|2017-02-22T10:40:21-08:00June 14, 2016|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Amplyx Pharmaceuticals Announces Qualified Infectious Disease Product Designation for APX001 in Three Life-threatening Fungal Infections
